RE:RE:RE:RE:RE:Let's Shifting Gears Here. Another Question 4 Anyone or All: lol..glad you got all of that out of your chest , it must have been really hard to carry all of that inside you . I'm guessing shorting / buying back what you sold must be the strategy here.. because definitely you're not writing like a bag holder looking for a rewarding outcome .. but then again We may be dealing with split personality here .. you lost me after the 10 th paragraph
quote=BitHorse]
I'm not in a position to quantify that which you would consider having made money. I've laid out what I believe to be a more than fair assessment of what the CEO has been up to on behalf of himself and more specifically to his blatant disregard for conflicts of interest. If I had to bet a dollar to a donut, I'd bet that it weighed heavily on Dr. Williams mind and it's likely partly a reason why he got the hell up out of here before he ruined his reputation. We have to remember this company's roots stem from King Flipper. He has right hand men still holding down management and director positions at the company. There's a lot of smoke and mirrors until an event happens and the truth gets revealed. Like Dr. Williams abrupt departure (right before the 1st data readout - are you kidding me?!) and suddenly two never before named doctors are brought to the fore. Yeah, it's all about the money. Damn caring to know how the sausage is getting made (plausible deniability - how admirable). Speaking of sausage - from 29M shares outstanding to 167M shares outstanding and not 1 clinical trial readout to date. Think about the cost of that. You have a company that has diluted the company 6 fold already with zero results from teeny tiny trials at 2 4 6 or so million a pop. How much dilution do you think will occur to run the phase 1 DMT clinical trial if ever? Something like 20 to 30 MIllion? How much dilution do you think that will create at the current share price? CJM is on the brink of a second reverse split of this company in record time.
The first reverse split:
“...effective October 17, 2018 (the “Share Consolidation”). The Company currently has 57,897,356 common shares issued and outstanding. Following the Share Consolidation, the Company will have approximately 28,948,678 common shares issued and outstanding. The new CUSIP number will be 10639L200 and the new ISIN number will be CA10639L2003.”
The only winners in all of this thus far is all the participants of the cheap shares/warrants financing. The money you are claiming you want to get your hands on keeps slipping through your fingers at every mention of the next clinical trial CJM wants to run (raise capital) but is having one helluva time actually getting to the Data Readout - The Payout. Sir, are you simply blind to the fact you’ve thus far had 3 chances to get to The Payout last year had CJM came through with any of his stories about getting data from the teeny tiny clinical trials? I'd challenge anyone to find a story anywhere in the biotech world that's missed 3 separate and consecutive clinical trial deadlines, and one clinical trial appears to have no plausible end in sight. Any CEO with that type of track record right out the gate, having dumping a medical device and getting absolutely nothing for it from Cannabix for financially helping to push the tech, would be viewed as incompetent in their job. You can’t chalk that up as simply bad luck. if you step back and really look at how the Breathtec Biomedical scenario played itself out - Breathtec Biomedical was nothing more than a financial vehicle used to help push Cannabix forward. Breathtec was never set up to succeed. That is proof positive. Well before they pulled the plug on the tech they went out and peddled the NA-NOSE device (shiny object). The NA-NOSE was just a distraction to keep shareholders thinking there was some there > there. There was nothing there. The NA-NOSE device had already circled the globe in sweeping clinical trials as a potential medical device well before Breathtec decided to get its hand on it. Breathtec handed over a stack of cash and cheap shares for the license to drive the device around Nowheresville, North America. When the exhaust smoke cleared, Kal was long gone with a boatload of cash from selling shares. CEO #2 had split town and went back to the University of Florida from whence he came. Dr. Richard Yost (we held him up as our hero) quietly snuck away from Breathtec. We found out he’d hightailed it out of there from Due Diligence by a poster who found Dr. Yost’s mugshot on our perceived #1 competitor’s website (Owlstone Medical) as a Scientific Advisor - the same Due Diligence way we found out Dr. Williams had established his own company and CJM claimed in a webcast Dr. Williams wasn’t going anywhere. You think that was a truthful answer? But I digress. Interim CEO #3 Alfred Wong (also a sidekick of Kal at Bullrun Capital at the time) held the spot down for approx 6 months until CJM came along as CEO #4. After the appointment of CJM we had not heard from our new CEO for the first 5 months of his tenure. % months...never a hello, how you doing, I’m your new CEO and glad to be here. CJM’s first official words to shareholders was the announcement of the NASH Pharmaceuticals deal that was called an acquisition but it was really a takeover of Breathtec Biomedical. From there they facilitated the takeover of Breathtec by NASH Pharmaceuticals. Thereafter, the massive dilution was off to the races. NASH disease was hyped up by the CEO for the longest but ultimately didn’t come firing out the clinical trial barrel as the leading drug candidate. Has anyone heard anything about NASH since? If I recall correctly, a primary reason CJM went with IPF/CC was because it was a speedy way to get some data results and potentially put some points on the board right out of the gate. How is that currently working out? A lot of old is new with this company, and some of the original players remain as well. It appears (or disappears) that one of the new players also doesn’t have a mugshot posted on the corporate website. So the management team is all of 4 people. A small group. Yet half of the management team won’t reveal themselves to us/all. You have to wonder, what do they have to hide? Then again, it’s another one of those management decisions. You get the leadership you deserve right?
TGIF
BH
[/quote]